These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 183683

  • 1. Epstein-Barr virus (EBV) specific T and K cell cytotoxicity in vitro.
    Jondal M, Svedmyr E, Klein E, Klein G.
    Bibl Haematol; 1975 Oct; (43):265-9. PubMed ID: 183683
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Seroepidemiology of Epstein-Barr virus].
    Pannuti CS.
    Rev Saude Publica; 1981 Feb; 15(1):93-100. PubMed ID: 6275491
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W, Henle G.
    Ann Clin Lab Sci; 1974 Feb; 4(2):109-14. PubMed ID: 4362218
    [No Abstract] [Full Text] [Related]

  • 6. Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection.
    Lai PK, Alpers MP.
    Comp Immunol Microbiol Infect Dis; 1979 Feb; 2(4):565-85. PubMed ID: 232867
    [No Abstract] [Full Text] [Related]

  • 7. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM.
    Acta Haematol Pol; 1979 Feb; 10(3):183-91. PubMed ID: 228518
    [No Abstract] [Full Text] [Related]

  • 8. Benign and malignant disease caused by EBV.
    Wolf H, Seibl R.
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):88s-95s. PubMed ID: 6330230
    [Abstract] [Full Text] [Related]

  • 9. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
    Henle W, Henle G.
    Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
    [Abstract] [Full Text] [Related]

  • 10. [Burkitt's lymphoma].
    Gombos F, Serpico R, Femiano F.
    Arch Stomatol (Napoli); 1984 Apr; 25(4):329-38. PubMed ID: 6100729
    [No Abstract] [Full Text] [Related]

  • 11. The sero-epidemiology of Epstein-Barr virus.
    Henle W, Henle G.
    Adv Pathobiol; 1976 Apr; (5):5-17. PubMed ID: 220858
    [No Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus and human malignancy.
    Ziegler JL, Magrath IT, Gerber P, Levine PH.
    Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.
    Ooka T, de Turenne-Tessier M, Stolzenberg MC.
    Springer Semin Immunopathol; 1991 Mar; 13(2):233-47. PubMed ID: 1664988
    [No Abstract] [Full Text] [Related]

  • 17. The Epstein-Barr virus and EB virus infections in childhood.
    Andiman WA.
    J Pediatr; 1979 Aug; 95(2):171-82. PubMed ID: 221638
    [No Abstract] [Full Text] [Related]

  • 18. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG, Britton S.
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
    Sugden B.
    Rev Infect Dis; 1982 Oct; 4(5):1048-61. PubMed ID: 6293034
    [Abstract] [Full Text] [Related]

  • 20. The oncogenicity of Epstein-Barr virus.
    Miller G.
    J Infect Dis; 1974 Aug; 130(2):187-205. PubMed ID: 4366977
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.